Dewpoint Therapeutics

Dewpoint Therapeutics is a biotechnology company applying the emerging science of biomolecular condensates to drug discovery. Founded in 2018 and headquartered in Boston, Massachusetts, with an additional research site in Dresden, Germany, Dewpoint has built an AI-powered, end-to-end platform (ERSA, powered by ERSAi) spanning target discovery, condensate-modulating (c-mod) drug discovery, optimization, and development. Its pipeline targets previously undruggable diseases across oncology, neurodegeneration, cardiopulmonary, and virology, with collaborations including Bayer, Novo Nordisk, Evotec, and Chemify. Dewpoint is a General Catalyst portfolio company; it operates internal research platforms and the open CD-CODE condensate knowledge platform (condensates.com), but does not publish a public developer API.

Dewpoint Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Drug Discovery, Pharmaceuticals, and Life Sciences.

Dewpoint Therapeutics’ developer surface includes engineering blog, support, and 5 more developer resources.

🌐 Visit website 📡 Source on GitHub

13.0/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyDrug DiscoveryPharmaceuticalsLife SciencesBiomolecular CondensatesArtificial IntelligenceOncologyNeurodegeneration

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 13.0/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/dewpoint-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 4

The organization behind the API

Website

About

Blog

Careers

Source (apis.yml)

aid: dewpoint-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/dewpoint-therapeutics.png
name: Dewpoint Therapeutics
description: Dewpoint Therapeutics is a biotechnology company applying the emerging science of biomolecular condensates to
  drug discovery. Founded in 2018 and headquartered in Boston, Massachusetts, with an additional research site in Dresden,
  Germany, Dewpoint has built an AI-powered, end-to-end platform (ERSA, powered by ERSAi) spanning target discovery, condensate-modulating
  (c-mod) drug discovery, optimization, and development. Its pipeline targets previously undruggable diseases across oncology,
  neurodegeneration, cardiopulmonary, and virology, with collaborations including Bayer, Novo Nordisk, Evotec, and Chemify.
  Dewpoint is a General Catalyst portfolio company; it operates internal research platforms and the open CD-CODE condensate
  knowledge platform (condensates.com), but does not publish a public developer API.
url: https://raw.githubusercontent.com/api-evangelist/dewpoint-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- general-catalyst
x-tier: stub
x-tier-reason: portfolio-lead
x-hq: 451 D Street, Suite 104, Boston, MA 02210, USA
x-founded: '2018'
x-api-surface: none
x-api-surface-note: Biotech drug-discovery company; internal ERSA/ERSAi platforms and the open CD-CODE research knowledge
  platform, but no public developer API as of 2026-07-18.
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotechnology
- Drug Discovery
- Pharmaceuticals
- Life Sciences
- Biomolecular Condensates
- Artificial Intelligence
- Oncology
- Neurodegeneration
apis: []
common:
- type: Website
  name: Dewpoint Therapeutics Website
  url: https://dewpointx.com/
- type: About
  name: About Dewpoint Therapeutics
  url: https://dewpointx.com/about-us/
- type: Blog
  name: News
  url: https://dewpointx.com/news/
- type: Support
  name: Contact
  url: https://dewpointx.com/contact/
- type: TermsOfService
  name: Terms of Service
  url: https://dewpointx.com/terms/
- type: PrivacyPolicy
  name: Privacy Policy
  url: https://dewpointx.com/privacy/
- type: Careers
  name: Careers
  url: https://dewpointx.com/careers/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence